BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 1661608)

  • 1. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
    J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience.
    Pritzker MR; Lake KD; Reutzel TJ; Hoffman FM; Jorgensen CR; Pederson W; Emery RW
    J Heart Lung Transplant; 1992; 11(2 Pt 2):415-20. PubMed ID: 1571339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation.
    Barr ML; Sanchez JA; Seche LA; Schulman LL; Smith CR; Rose EA
    Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of induction therapy on rejection and survival in heart transplantation.
    Almenar L; García-Palomar C; Martínez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Osa A; Cardo ML
    Transplant Proc; 2005 Nov; 37(9):4024-7. PubMed ID: 16386616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The duration of administration of monoclonal antibody OKT3 for induction immunosuppression after heart transplantation.
    Aleksic I; Freimark D; Blanche C; Czer LS; Dalichau H; Valenza M; Takkenberg JJ; Trento A
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):190-5. PubMed ID: 9323821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic cytolytic therapy in heart transplantation: monoclonal versus polyclonal antibody therapy.
    Laske A; Gallino A; Schneider J; Bauer EP; Carrel T; Pasic M; von Segesser LK; Turina MI
    J Heart Lung Transplant; 1992; 11(3 Pt 1):557-63. PubMed ID: 1610864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique antithymocyte serum versus OKT3 for induction immunotherapy after heart transplantation.
    Frist WH; Merrill WH; Eastburn TE; Atkinson JB; Stewart JR; Hammon JW; Bender JW
    J Heart Transplant; 1990; 9(5):489-94. PubMed ID: 2121921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M; Latter DA; Loertscher R
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation.
    Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Winters GL; Pifarre R; Radvany R; Zucker MJ; Scanlon PJ; Robinson JA
    J Heart Transplant; 1990; 9(3 Pt 2):306-15. PubMed ID: 2113094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
    Hegewald MG; O'Connell JB; Renlund DG; Lee HR; Burton NA; Karwande SV; Jones KW; Lassetter JE; Bristow MR
    J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts.
    Menkis AH; Powell AM; Novick RJ; McKenzie FN; Kostuk WJ; Pflugfelder PW; Brown JE; Rochon J; Chow LH; Stiller C
    J Heart Lung Transplant; 1992; 11(3 Pt 1):569-76. PubMed ID: 1610866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
    Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL
    J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
    Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM
    Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic OKT3 used as induction therapy for heart transplantation.
    Starnes VA; Oyer PE; Stinson EB; Dein JR; Shumway NE
    Circulation; 1989 Nov; 80(5 Pt 2):III79-83. PubMed ID: 2509108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-drug immunosuppression for heart transplantation in infants and children.
    Brown JW; Turrentine MW; Kesler KA; Mahomed Y; Darragh R; Evans K; Thompson L; Caldwell R
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S265-74. PubMed ID: 8312346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation.
    Keogh A; Macdonald P; Mundy J; Chang V; Harvison A; Spratt P
    J Heart Lung Transplant; 1992; 11(3 Pt 1):550-5; discussion 556. PubMed ID: 1610863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.